Related Experiment Video
Updated: Apr 26, 2026

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides
Jie Zhao1, Sreya Bagchi1, Chyung-Ru Wang1
1Department of Microbiology and Immunology; Feinberg School of Medicine; Northwestern University; Chicago, IL USA.
Abstract:
Type II natural killer T (NKT) cells in cancer immunity are typically associated with suppression of tumor immunosurveillance through secretion of IL-13. We previously demonstrated that CpG oligonucleotide therapy activated Type II NKT cells to produce T helper type 1 (Th1) rather than T helper type 2 (Th2) cytokines. This cytokine skewing may manifest in Type II NKT cell antitumor properties in an immunotherapeutic setting.
Insights
CpG oligonucleotide therapy shifts Type II natural killer T (NKT) cells from producing immunosuppressive IL-13 to cancer-fighting Th1 cytokines. This reprogramming offers potential for novel cancer immunotherapy strategies.
Area of Science:
- Immunology
- Cancer Research
- Immunotherapy
Background:
- Type II natural killer T (NKT) cells typically suppress anti-tumor immunity by secreting IL-13.
- This immunosuppressive function hinders effective tumor immunosurveillance.
Purpose of the Study:
- To investigate the effect of CpG oligonucleotide therapy on Type II NKT cell cytokine production.
- To determine if this therapy can redirect Type II NKT cells towards an anti-tumor phenotype.
Main Methods:
- Administration of CpG oligonucleotide therapy.
- Analysis of cytokine profiles produced by Type II NKT cells post-therapy.
Main Results:
- CpG oligonucleotide therapy activated Type II NKT cells to produce T helper type 1 (Th1) cytokines.
- This represents a shift away from the typical T helper type 2 (Th2) cytokine profile (IL-13).
Conclusions:
- CpG oligonucleotide therapy can reprogram Type II NKT cells to produce anti-tumor Th1 cytokines.
- This cytokine skewing suggests a potential role for Type II NKT cells in cancer immunotherapy.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

